SOR-C13 (trifluoroacetate salt) |
| Katalog-Nr.GC52397 |
A peptide TRPV6 antagonist
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
SOR-C13 is a peptide antagonist of transient receptor potential vanilloid 6 (TRPV6).1 It inhibits calcium flux in HEK293 cells expressing human TRPV6 (EC50 = 14 nM). SOR-C13 (400, 600, and 800 mg/kg) reduces tumor volume in an SKOV3 ovarian cancer mouse xenograft model.
1.Xue, H., Wang, Y., MacCormack, T.J., et al.Inhibition of Transient Receptor Potential Vanilloid 6 channel, elevated in human ovarian cancers, reduces tumour growth in a xenograft modelJ. Cancer9(17)3196-3207(2018)
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *